Correspondence: The First Biosimilar for Biologics in Allergy: <scp>CT</scp> ‐ <scp>P39</scp> (Omlyclo‐Omalizumab‐Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps
Authors
Laura Van Gerven (ORCID: https://orcid.org/0000-0002-5325-7956)
J Bousquet
Markus W. Ollert (ORCID: https://orcid.org/0000-0002-8055-0103)
Correspondence: The First Biosimilar for Biologics in Allergy: CT ‐ P39 (Omlyclo‐Omalizumab‐Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps
Laura Van Gerven, J Bousquet, Markus W. Ollert, S. Toppila-Salmi et al.
Journal
Allergy
Topics
Biosimilars and Bioanalytical Methods
article
Correspondence: The First Biosimilar for Biologics in Allergy: CT ‐ P39 (Omlyclo‐Omalizumab‐Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps
Laura Van Gerven, J Bousquet, Markus W. Ollert, S. Toppila-Salmi, R Gawlik, Ludger Klimek, Marie Lundberg, Sietze Reitsma, Stefania Arasi, Juan M. Solano, María Marta Escribese, Joaquim Mullol, Jan Hagemann, M. Sokolowska, M. J. Torres Jaen, P. Bonadonna, S. Becker, M. Shamji, C. Akdis, E. De Corso, F. Bärhold, V Hox, O. Palomares, A. Moreira, I. M. Adcock
article en
Abstract
No abstract available for this paper.
Publication Tag
Allergy
Institutions
Universidad San Pablo CEU (ES), University of Verona (IT), Universidad Complutense de Madrid (ES), Cliniques Universitaires Saint-Luc (BE), University of Helsinki (FI), International Federation of Red Cross and Red Crescent Societies (CH), Vrije Universiteit Brussel (BE), Medical University of Silesia (PL), University of Eastern Finland (FI), Universidade do Porto (PT), Johannes Gutenberg University Mainz (DE), University of Zurich (CH), Helsinki University Hospital (FI), Hospital de São João (PT), Humboldt-Universität zu Berlin (DE), Azienda Ospedaliera di Perugia (IT), Centre Hospitalier Universitaire de Montpellier (FR), Hospital Quirónsalud Sagrado Corazón (ES), Luxembourg Institute of Health (LU), Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie (DE), Hospital Regional Universitario de Málaga (ES), NIHR Imperial Biomedical Research Centre (GB), Hospital Clínic de Barcelona (ES), Ospedale Santa Maria (IT), Zentrum für Rhinologie und Allergologie (DE), Bambino Gesù Children's Hospital (IT), Universitair Ziekenhuis Brussel (BE), Asthma Association (BG), Amsterdam University Medical Centers (NL), Hospital Universitario Virgen del Rocío (ES), i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto (PT), Instituto de Investigación Biomédica de Málaga (ES), Imperial College London (GB), Universidad de Sevilla (ES), University of Tübingen (DE), University of Silesia in Katowice (PL), University of Amsterdam (NL), KU Leuven (BE)